CRISPR / Cas9 is revolutionizing the field of mouse gene targeting. Mice have been very useful in the laboratory, and the first choice for studying mammalian biology. Methods obtaining knockout mice by ES cell homologous recombination often take a long time and are inefficient, and the success is not always guaranteed. As an emerging genetic editing technology, CRISPR/Cas9 can be used as a substitute for traditional gene-editing technology and has revolutionized the production of transgenic animals. This system shows unprecedented efficiency, reusability, and ease of use, reducing the time and cost of genome editing and enabling the production of animals with a wider range of genetic modifications. CRISPR/Cas9 PlatformCB is a professional genetic editing biotechnology company that specializes in providing transgenic mouse models for biomedical research and drug discovery. CRISPR/Cas9 PlatformCB has independent experimental design strategies and verification methods, and successfully generated mouse models with fast turnaround and low cost. Based on our platform, we can knock out the targeted gene you interest in mice by CRISPR/Cas9 technology and complete in 3-5 months. We guarantee delivery of at least 2 founders or 3 F1 animals for the knockout.

CRISPR / Cas9 is revolutionizing the field of mouse gene targeting. Mice have been very useful in the laboratory, and the first choice for studying mammalian biology. Methods obtaining knockout mice by ES cell homologous recombination often take a long time and are inefficient, and the success is not always guaranteed. As an emerging genetic editing technology, CRISPR/Cas9 can be used as a substitute for traditional gene-editing technology and has revolutionized the production of transgenic animals. This system shows unprecedented efficiency, reusability, and ease of use, reducing the time and cost of genome editing and enabling the production of animals with a wider range of genetic modifications. CRISPR/Cas9 PlatformCB is a professional genetic editing biotechnology company that specializes in providing transgenic mouse models for biomedical research and drug discovery. CRISPR/Cas9 PlatformCB has independent experimental design strategies and verification methods, and successfully generated mouse models with fast turnaround and low cost. Based on our platform, we can knock out the targeted gene you interest in mice by CRISPR/Cas9 technology and complete in 3-5 months. We guarantee delivery of at least 2 founders or 3 F1 animals for the knockout.